Vincristine Sulphate Injection Biocristin

Product/Composition Vincristine Sulphate Injection
Strength 1mg/ml
Form Injection
Production Capacity 10 Million Vials/Month
Packaging 1 Vial / Box
Therapeutic use Hematological Malignancies & Selected Solid Tumors
Package Insert/Leaflet Available upon request
Brand Name Biocristin

Vincristine Sulphate Injection – Biocristin is a cytotoxic anticancer medicine containing Vincristine Sulphate, a vinca alkaloid used in combination chemotherapy regimens for various hematological malignancies and selected solid tumors.

Vincristine works by interfering with microtubule formation, an essential process for cell division. By disrupting mitosis, it prevents rapidly dividing cancer cells from progressing through the cell cycle.

Biocristin is administered by qualified healthcare professionals under the supervision of an oncologist. The dose and treatment schedule are determined according to the patient’s condition, chemotherapy protocol, body surface area, and clinical response.

What is Vincristine Sulphate?

Vincristine Sulphate is a vinca alkaloid antineoplastic agent. It binds to tubulin and disrupts microtubule formation, thereby interfering with mitotic spindle development and preventing cell division.

It is commonly incorporated into multi-drug chemotherapy protocols rather than being used as a standalone treatment.

Benefits / Uses

Vincristine Sulphate Injection may be used as part of combination chemotherapy for:

  • Acute lymphoblastic leukemia (ALL)
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Neuroblastoma
  • Wilms tumor
  • Rhabdomyosarcoma
  • Selected hematological malignancies
  • Other cancers according to established oncology protocols

The exact indication and chemotherapy combination depend on the patient’s diagnosis and the treating oncologist’s protocol.

Dosage Guidelines

Vincristine is administered intravenously only by appropriately trained healthcare professionals.

  • The dose is generally calculated according to body-surface area and the applicable chemotherapy protocol.
  • Administration is usually performed at defined intervals within a combination chemotherapy regimen.
  • Dose modifications may be required depending on toxicity, liver function, age, and other clinical factors.
  • Vincristine must never be administered intrathecally, as accidental intrathecal administration can be fatal.

The dosage and administration schedule should always follow the prescribing information and oncologist’s instructions.

Wholesale & Supply

Biocristin – Vincristine Sulphate Injection can be supplied for hospitals, oncology centers, pharmaceutical distributors, wholesalers, and international healthcare markets, subject to applicable regulatory requirements.

Bulk buyers can request:

  • Available strengths and presentations
  • Packaging details
  • Minimum order quantity
  • Production and supply capacity
  • Certificate of Analysis (CoA)
  • Product documentation
  • Regulatory and export documents

Buying Online

Vincristine Sulphate is a prescription cytotoxic chemotherapy medicine and should only be purchased through authorized pharmaceutical suppliers and used under appropriate medical supervision.

Hospitals, licensed distributors, and healthcare procurement organizations can contact the supplier for product availability, commercial quotations, and applicable documentation.

Reviews

Individual responses to Vincristine-based chemotherapy can vary according to the type and stage of cancer, treatment combination, and patient characteristics. Product reviews should not replace professional medical assessment or established oncology treatment protocols.

Quality Assurance

Biocristin should be manufactured and handled according to applicable pharmaceutical quality requirements. Quality-control testing for injectable products may include:

  • Identity and assay
  • Sterility
  • Purity and related substances
  • Appearance
  • Particulate matter
  • Container-closure integrity
  • Stability testing
  • Appropriate storage conditions

Product-specific quality and regulatory documentation can be provided upon request, where applicable.

Frequently Asked Questions

What is Biocristin used for?

Biocristin contains Vincristine Sulphate and is used as part of combination chemotherapy for several hematological malignancies and selected solid tumors.

What type of medicine is Vincristine Sulphate?

Vincristine Sulphate is a vinca alkaloid and cytotoxic antineoplastic medicine that interferes with microtubule formation and cell division.

How is Biocristin Injection administered?

Biocristin is administered intravenously by qualified healthcare professionals. It must not be administered intrathecally.

Is Vincristine used alone?

Vincristine is generally used as part of combination chemotherapy regimens with other anticancer medicines selected according to the specific cancer and treatment protocol.

What are the important side effects of Vincristine?

Potential adverse effects include peripheral neuropathy, constipation, abdominal discomfort, hair loss, and other chemotherapy-related toxicities. Neurological toxicity can be clinically significant and requires monitoring.

Does Biocristin require specialist supervision?

Yes. Vincristine is a potent cytotoxic chemotherapy medicine and should be prepared, administered, and monitored by appropriately trained healthcare professionals.

Conclusion

Biocristin – Vincristine Sulphate Injection is a vinca alkaloid chemotherapy medicine used in established combination treatment protocols for various hematological malignancies and selected cancers. Because of its cytotoxic activity and potential for serious neurological toxicity, it requires strict adherence to oncology protocols and professional administration.